My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Iberoamerican Journal of Medicine
On-line version ISSN 2695-5075Print version ISSN 2695-5075
Abstract
DASH, Debabrata and MERCHANT, Shahid A.. Bioresorbable scaffolds: current concepts and future technology. Iberoam J Med [online]. 2022, vol.4, n.4, pp.237-247. Epub Dec 04, 2023. ISSN 2695-5075. https://dx.doi.org/10.53986/ibjm.2022.0034.
The introduction of the drug-eluting (DES) stent to percutaneous coronary intervention (PCI) had a significant impact on patient management of coronary artery disease and has been called the "third revolution" in interventional cardiology after the first 2 revolutions of balloon angioplasty and bare-metal stents. The promise of adaptive remodeling, restoration of vasomotion, late luminal enlargement, and retained potential for future coronary artery bypass grafting at the site of previous PCI has been the driving force behind bioresorbable stent/scaffold (BRS) technology development. Moreover, because of the inherent risk of late and very late stent thrombosis, BRS potentially offers a solution and recent years have seen heightened interest, hype, and hope. In this current review, we are aiming to shed light on strength and weakness of various BRS including the future perspective.
Keywords : Bioresorbable scaffolds; Angioplasty; Coronary stents.